7531-49-9Relevant articles and documents
NOVEL ANTI-INFLAMMATORY PRO-DRUGS
-
Page/Page column 31-32, (2009/01/24)
The present invention relates to compounds according to formula (I): wherein R is selected from the group consisting of anti-inflammatory agents and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising compounds of formula (I) and the use of these pharmaceutical compositions for the treatment or prophylaxis of chronic inflammatory diseases, in particular those that are caused by chronically activated macrophages. The chronic inflammatory disease is in particular atherosclerosis, (rheumatoid) arthritis, an (auto)immune disease or sarcoidosis.
Probing the mechanism of a fungal glycosyltransferase essential for cell wall biosynthesis. UDP-Chitobiose is not a substrate for chitin synthase
Chang, Robert,Yeager, Adam R.,Finney, Nathaniel S.
, p. 39 - 41 (2007/10/03)
Chitin synthase is responsible for the biosynthesis of chitin, an essential component of the fungal cell wall. There is a long-standing question as to whether "processive" transferases such as chitin synthase operate in the same manner as non-processive transferases. The question arises from analysis of the polysaccharide structure - in chitin, for instance, each sugar residue is rotated ca. 180 deg relative to the preceding sugar in the chain. This requires that the enzyme account for the alternating "up/down" configuration during biosynthesis. An enzyme with a single active site, analogous to the non-processive transferases - would have to accommodate a distorted glycosidic linkage at every other synthetic step. An alternative proposal is that the enzyme might assemble the disaccharide donor, addressing the "up/down" conformational problem prior to polymer synthesis. We present compelling evidence that this latter hypothesis is incorrect.
Kombinierte chemoenzymatische Synthese von N-Glycoproteinbausteinen
Thiem, Joachim,Wiemann, Torsten
, p. 78 - 80 (2007/10/02)
-